Arthromeda Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2.44M

  • Investors
  • 1

Arthromeda General Information

Description

Developer of patient-specific medical technologies designed to offer cost-effective outcomes for improved arthroplasty surgery. The company's technologies utilize micro-sensors, wireless systems, and custom software applications to reduce operating room time, improve patient outcomes, and reduce the cost burden associated with early implant failure, enabling surgeons to minimize implant failure and revision rates.

Contact Information

Formerly Known As
ArthroCAD
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 172 Middle Street
  • Suite 207
  • Lowell, MA 01852
  • United States
+1 (781)
Primary Industry
Outcome Management (Healthcare)
Vertical(s)
Corporate Office
  • 172 Middle Street
  • Suite 207
  • Lowell, MA 01852
  • United States
+1 (781)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Arthromeda Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 04-Feb-2025 $2.44M Completed Generating Revenue
6. Later Stage VC (Series F) 06-Jan-2020 Completed Generating Revenue
5. Later Stage VC (Series E) 29-Jun-2018 Completed Generating Revenue
4. Later Stage VC (Series D) 01-Jun-2017 Completed Generating Revenue
3. Later Stage VC (Series C) 24-Mar-2016 Completed Startup
2. Early Stage VC (Series B) 06-Jan-2014 $1.64M $2.42M Completed Startup
1. Early Stage VC (Series A) 11-Jan-2013 $775K $775K Completed Startup
To view Arthromeda’s complete valuation and funding history, request access »

Arthromeda Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E
Series D
Series C
Series B 3,530,971 $0.000100 6% $0.68 $0.68 1x $0.68 22.07%
Series A 1,301,961 $0.000100 6% $0.6 $0.6 1x $0.6 8.14%
To view Arthromeda’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Arthromeda Patents

Arthromeda Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2017264879-A1 Patient-specific prosthesis alignment Inactive 11-May-2016
EP-3454729-A1 Patient-specific prosthesis alignment Inactive 11-May-2016
US-20170325892-A1 Patient-specific prosthesis alignment Inactive 11-May-2016
EP-3454729-A4 Patient-specific prosthesis alignment Inactive 11-May-2016
US-20200163721-A1 Patient-specific prosthesis alignment Inactive 11-May-2016 A61B34/10
To view Arthromeda’s complete patent history, request access »

Arthromeda Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Thornapple River Capital Venture Capital Minority
To view Arthromeda’s complete investors history, request access »

Arthromeda FAQs

  • When was Arthromeda founded?

    Arthromeda was founded in 2011.

  • Where is Arthromeda headquartered?

    Arthromeda is headquartered in Lowell, MA.

  • What industry is Arthromeda in?

    Arthromeda’s primary industry is Outcome Management (Healthcare).

  • Is Arthromeda a private or public company?

    Arthromeda is a Private company.

  • What is Arthromeda’s current revenue?

    The current revenue for Arthromeda is .

  • How much funding has Arthromeda raised over time?

    Arthromeda has raised $11.3M.

  • Who are Arthromeda’s investors?

    Thornapple River Capital has invested in Arthromeda.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »